TY - JOUR
T1 - Effect of nitric oxide synthase inhibitors on basal microvessel permeability and endothelial cell [Ca2+]i
AU - He, P.
AU - Zeng, M.
AU - Curry, F. E.
PY - 1997
Y1 - 1997
N2 - We evaluated the role of basal nitric oxide (NO) release in the regulation of microvessel permeability under resting conditions. We measured changes in microvessel hydraulic conductivity (Lp) and endothelial cytoplasmic calcium concentration ([Ca2+]i) after application of NO synthase (NOS) inhibitors to the lumen of individually perfused frog mesenteric venular microvessels. NOS inhibitors caused a transient increase in Lp. The mean ratios of peak test Lp values relative to control values in the presence of AKnitro-L-arginine methyl ester (L-NAME) at concentrations of 1,10, and 100 μM were 2.5 ±0.6, 2.9 ± 0.7, and 4.8 ±0.4, respectively. N-monomethyl-L-argmine (L-NMMA) showed a similar effect and a biologically inactive isomer of L-NMMA, D-NMMA, showed no effect. These results demonstrate that basal levels of NO play a role in modulating microvessel permeability different from that due to NO produced in response to inflammatory agents. In the activated state NOS inhibitors attenuated the increased microvessel permeability in response to ionomycin and ATP [P. He, B. Liu, and F. E. Curry. Am. J. Physlol. 272 (Heart Circ. Physiol. 41): H176-H185, 1997]. The transient increase in basal permeability induced by NOS inhibitors was not accompanied by an increase in endothelial cell [Ca2+]j and did not require the presence of extracellular calcium. Application of ketotifen, a mast cell stabilizer, and an iron-chelating reagent, deferoxamine mesylate, attenuated the transient increase in Lp induced by L-NMMA, suggesting that basal NO may have an important antioxidant role in regulating normal permeability.
AB - We evaluated the role of basal nitric oxide (NO) release in the regulation of microvessel permeability under resting conditions. We measured changes in microvessel hydraulic conductivity (Lp) and endothelial cytoplasmic calcium concentration ([Ca2+]i) after application of NO synthase (NOS) inhibitors to the lumen of individually perfused frog mesenteric venular microvessels. NOS inhibitors caused a transient increase in Lp. The mean ratios of peak test Lp values relative to control values in the presence of AKnitro-L-arginine methyl ester (L-NAME) at concentrations of 1,10, and 100 μM were 2.5 ±0.6, 2.9 ± 0.7, and 4.8 ±0.4, respectively. N-monomethyl-L-argmine (L-NMMA) showed a similar effect and a biologically inactive isomer of L-NMMA, D-NMMA, showed no effect. These results demonstrate that basal levels of NO play a role in modulating microvessel permeability different from that due to NO produced in response to inflammatory agents. In the activated state NOS inhibitors attenuated the increased microvessel permeability in response to ionomycin and ATP [P. He, B. Liu, and F. E. Curry. Am. J. Physlol. 272 (Heart Circ. Physiol. 41): H176-H185, 1997]. The transient increase in basal permeability induced by NOS inhibitors was not accompanied by an increase in endothelial cell [Ca2+]j and did not require the presence of extracellular calcium. Application of ketotifen, a mast cell stabilizer, and an iron-chelating reagent, deferoxamine mesylate, attenuated the transient increase in Lp induced by L-NMMA, suggesting that basal NO may have an important antioxidant role in regulating normal permeability.
KW - Deferoxamine mesylate
KW - Hydraulic conductivity
KW - Individually perfused microvessels
KW - Iron-chelating reagent
KW - Ketotifen
KW - Mast cell stabilizer
UR - http://www.scopus.com/inward/record.url?scp=33751293359&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33751293359&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:33751293359
VL - 42
JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology
JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology
SN - 1931-857X
IS - 2
ER -